Close Menu

NEW YORK – 23andMe has received 510(k) clearance from the US Food and Drug Administration for its CYP2C19 Drug Metabolism Report, which informs customers whether their genotypes may influence their ability to respond to clopidogrel and citalopram without the need for confirmatory testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.